← Back to Search

Inhaled Analgesic

intervention Arm for Acute Pain

Phase 4
Waitlist Available
Led By Michael A Austin, MD
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up for length of study, up to 100 patients
Awards & highlights

Study Summary

This trial is testing a new pain reliever to see if it is safe and effective. If it is, it could be used by paramedics to help people in pain.

Eligible Conditions
  • Acute Pain
  • Trauma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from patient contact to transfer of care
This trial's timeline: 3 weeks for screening, Varies for treatment, and from patient contact to transfer of care for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluation of outcome data collected
Study protocol compliance by paramedics
Time to ethics approval for single site
+1 more
Secondary outcome measures
Adverse events post administration of methoxyflurane
Need for rescue medication (as defined by addition of any other pain medication after methoxyflurane administration, during paramedic care)
Methoxyflurane
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: intervention ArmExperimental Treatment1 Intervention
Methoxyflurane will be introduced and data will be captured to inform future multicentred step wedge design study. (This study is a feasibility study)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Methoxyflurane
FDA approved

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor
561 Previous Clinical Trials
2,785,597 Total Patients Enrolled
2 Trials studying Acute Pain
225 Patients Enrolled for Acute Pain
University of OttawaOTHER
207 Previous Clinical Trials
267,044 Total Patients Enrolled
Michael A Austin, MDPrincipal InvestigatorOttawa Hospital Research Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~24 spots leftby Apr 2025